STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 252.65 Million USD | 13.1% |
| 2022 | 223.38 Million USD | 25.05% |
| 2021 | 178.63 Million USD | 50.92% |
| 2020 | 118.36 Million USD | 5.72% |
| 2019 | 111.95 Million USD | 22.34% |
| 2018 | 91.51 Million USD | 42.36% |
| 2017 | 64.28 Million USD | 10.13% |
| 2016 | 58.36 Million USD | 10.71% |
| 2015 | 52.72 Million USD | 7.99% |
| 2014 | 48.82 Million USD | -2.95% |
| 2013 | 50.3 Million USD | 13.59% |
| 2012 | 44.29 Million USD | 4.54% |
| 2011 | 42.36 Million USD | 20.79% |
| 2010 | 35.07 Million USD | -16.27% |
| 2009 | 41.89 Million USD | 4.45% |
| 2008 | 40.1 Million USD | 37.04% |
| 2007 | 29.26 Million USD | 10.72% |
| 2006 | 26.43 Million USD | 11.13% |
| 2005 | 23.78 Million USD | -9.02% |
| 2004 | 26.14 Million USD | -6.09% |
| 2003 | 27.83 Million USD | 15.27% |
| 2002 | 24.14 Million USD | 9.6% |
| 2001 | 22.03 Million USD | -29.8% |
| 2000 | 31.38 Million USD | -22.12% |
| 1999 | 40.3 Million USD | 0.5% |
| 1998 | 40.1 Million USD | 12.32% |
| 1997 | 35.7 Million USD | 4.08% |
| 1996 | 34.3 Million USD | 23.38% |
| 1995 | 27.8 Million USD | 23.01% |
| 1994 | 22.6 Million USD | 32.94% |
| 1993 | 17 Million USD | 117.95% |
| 1992 | 7.8 Million USD | 239.13% |
| 1991 | 2.3 Million USD | -8.0% |
| 1990 | 2.5 Million USD | 192.59% |
| 1989 | -2.7 Million USD | -125.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 61.03 Million USD | 0.51% |
| 2024 Q2 | 78.41 Million USD | 28.47% |
| 2024 Q3 | 68.48 Million USD | -12.66% |
| 2023 Q3 | 63.63 Million USD | -10.02% |
| 2023 FY | 252.65 Million USD | 13.1% |
| 2023 Q4 | 60.72 Million USD | -4.58% |
| 2023 Q1 | 57.56 Million USD | 15.62% |
| 2023 Q2 | 70.72 Million USD | 22.87% |
| 2022 Q3 | 60.46 Million USD | -5.34% |
| 2022 FY | 223.38 Million USD | 25.05% |
| 2022 Q1 | 49.26 Million USD | 9.5% |
| 2022 Q2 | 63.87 Million USD | 29.65% |
| 2022 Q4 | 49.78 Million USD | -17.66% |
| 2021 Q1 | 39.14 Million USD | 14.11% |
| 2021 Q2 | 49.2 Million USD | 25.7% |
| 2021 FY | 178.63 Million USD | 50.92% |
| 2021 Q3 | 45.3 Million USD | -7.93% |
| 2021 Q4 | 44.99 Million USD | -0.68% |
| 2020 FY | 118.36 Million USD | 5.72% |
| 2020 Q2 | 24.43 Million USD | -1.33% |
| 2020 Q3 | 34.87 Million USD | 42.74% |
| 2020 Q4 | 34.3 Million USD | -1.63% |
| 2020 Q1 | 24.76 Million USD | -14.1% |
| 2019 Q2 | 29.89 Million USD | 23.65% |
| 2019 Q1 | 24.18 Million USD | 5.17% |
| 2019 FY | 111.95 Million USD | 22.34% |
| 2019 Q4 | 28.82 Million USD | -0.78% |
| 2019 Q3 | 29.05 Million USD | -2.84% |
| 2018 Q4 | 22.99 Million USD | -3.64% |
| 2018 Q2 | 25.22 Million USD | 29.83% |
| 2018 Q1 | 19.43 Million USD | 11.8% |
| 2018 FY | 91.51 Million USD | 42.36% |
| 2018 Q3 | 23.86 Million USD | -5.42% |
| 2017 FY | 64.28 Million USD | 10.13% |
| 2017 Q4 | 17.38 Million USD | 3.15% |
| 2017 Q3 | 16.84 Million USD | 8.89% |
| 2017 Q2 | 15.47 Million USD | 6.15% |
| 2017 Q1 | 14.57 Million USD | -8.19% |
| 2016 Q4 | 15.87 Million USD | 6.76% |
| 2016 Q1 | 12.99 Million USD | -11.4% |
| 2016 Q2 | 14.62 Million USD | 12.57% |
| 2016 FY | 58.36 Million USD | 10.71% |
| 2016 Q3 | 14.87 Million USD | 1.68% |
| 2015 Q1 | 12.89 Million USD | 37.18% |
| 2015 Q3 | 12.79 Million USD | 3.54% |
| 2015 FY | 52.72 Million USD | 7.99% |
| 2015 Q4 | 14.66 Million USD | 14.57% |
| 2015 Q2 | 12.36 Million USD | -4.17% |
| 2014 Q3 | 11.86 Million USD | -13.16% |
| 2014 Q1 | 13.88 Million USD | 7.0% |
| 2014 Q2 | 13.66 Million USD | -1.56% |
| 2014 FY | 48.82 Million USD | -2.95% |
| 2014 Q4 | 9.4 Million USD | -20.78% |
| 2013 Q4 | 12.97 Million USD | 7.6% |
| 2013 FY | 50.3 Million USD | 13.59% |
| 2013 Q1 | 12.65 Million USD | 13.31% |
| 2013 Q2 | 12.62 Million USD | -0.27% |
| 2013 Q3 | 12.05 Million USD | -4.45% |
| 2012 Q2 | 11.04 Million USD | 1.31% |
| 2012 Q1 | 10.9 Million USD | -4.61% |
| 2012 Q4 | 11.16 Million USD | -0.07% |
| 2012 Q3 | 11.17 Million USD | 1.19% |
| 2012 FY | 44.29 Million USD | 4.54% |
| 2011 FY | 42.36 Million USD | 20.79% |
| 2011 Q3 | 10.45 Million USD | -3.78% |
| 2011 Q2 | 10.86 Million USD | 12.79% |
| 2011 Q4 | 11.42 Million USD | 9.37% |
| 2011 Q1 | 9.62 Million USD | 3.45% |
| 2010 Q2 | 8.67 Million USD | -1.7% |
| 2010 FY | 35.07 Million USD | -16.27% |
| 2010 Q4 | 9.3 Million USD | 12.69% |
| 2010 Q3 | 8.26 Million USD | -4.83% |
| 2010 Q1 | 8.82 Million USD | -20.13% |
| 2009 Q1 | 10.33 Million USD | -0.2% |
| 2009 FY | 41.89 Million USD | 4.45% |
| 2009 Q4 | 11.05 Million USD | 12.39% |
| 2009 Q3 | 9.83 Million USD | -7.77% |
| 2009 Q2 | 10.66 Million USD | 3.14% |
| 2008 FY | 40.1 Million USD | 37.04% |
| 2008 Q1 | 7.75 Million USD | -2.62% |
| 2008 Q2 | 11.53 Million USD | 48.73% |
| 2008 Q3 | 10.45 Million USD | -9.33% |
| 2008 Q4 | 10.36 Million USD | -0.94% |
| 2007 FY | 29.26 Million USD | 10.72% |
| 2007 Q1 | 7.29 Million USD | 10.65% |
| 2007 Q2 | 7.23 Million USD | -0.8% |
| 2007 Q3 | 6.77 Million USD | -6.45% |
| 2007 Q4 | 7.96 Million USD | 17.64% |
| 2006 Q4 | 6.59 Million USD | 3.0% |
| 2006 FY | 26.43 Million USD | 11.13% |
| 2006 Q3 | 6.4 Million USD | -9.08% |
| 2006 Q1 | 6.39 Million USD | 15.76% |
| 2006 Q2 | 7.04 Million USD | 10.02% |
| 2005 Q4 | 5.52 Million USD | 6.37% |
| 2005 FY | 23.78 Million USD | -9.02% |
| 2005 Q2 | 6.61 Million USD | 2.48% |
| 2005 Q3 | 5.19 Million USD | -21.38% |
| 2005 Q1 | 6.45 Million USD | -1.96% |
| 2004 Q2 | 6.15 Million USD | -15.95% |
| 2004 Q4 | 6.57 Million USD | 7.91% |
| 2004 Q1 | 7.31 Million USD | 1.41% |
| 2004 FY | 26.14 Million USD | -6.09% |
| 2004 Q3 | 6.09 Million USD | -0.86% |
| 2003 Q2 | 7.05 Million USD | 1.79% |
| 2003 FY | 27.83 Million USD | 15.27% |
| 2003 Q1 | 6.93 Million USD | 2.05% |
| 2003 Q3 | 6.58 Million USD | -6.65% |
| 2003 Q4 | 7.21 Million USD | 9.53% |
| 2002 Q3 | 5.62 Million USD | -6.71% |
| 2002 Q1 | 5.71 Million USD | 0.94% |
| 2002 Q2 | 6.02 Million USD | 5.46% |
| 2002 FY | 24.14 Million USD | 9.6% |
| 2002 Q4 | 6.79 Million USD | 20.87% |
| 2001 Q3 | 6.68 Million USD | 258.61% |
| 2001 Q1 | 8.37 Million USD | -2.67% |
| 2001 Q2 | 1.86 Million USD | -77.74% |
| 2001 FY | 22.03 Million USD | -29.8% |
| 2001 Q4 | 5.65 Million USD | -15.39% |
| 2000 Q3 | 9.29 Million USD | 157.88% |
| 2000 Q4 | 8.6 Million USD | -7.38% |
| 2000 FY | 31.38 Million USD | -22.12% |
| 2000 Q2 | 3.6 Million USD | -63.53% |
| 2000 Q1 | 9.88 Million USD | -5.88% |
| 1999 Q3 | 9.6 Million USD | -4.0% |
| 1999 FY | 40.3 Million USD | 0.5% |
| 1999 Q4 | 10.5 Million USD | 9.38% |
| 1999 Q2 | 10 Million USD | -0.99% |
| 1999 Q1 | 10.1 Million USD | 23.17% |
| 1998 Q1 | 11.1 Million USD | 54.17% |
| 1998 FY | 40.1 Million USD | 12.32% |
| 1998 Q4 | 8.2 Million USD | -13.68% |
| 1998 Q3 | 9.5 Million USD | -15.93% |
| 1998 Q2 | 11.3 Million USD | 1.8% |
| 1997 Q3 | 9.9 Million USD | 1.02% |
| 1997 Q4 | 7.2 Million USD | -27.27% |
| 1997 Q2 | 9.8 Million USD | 16.67% |
| 1997 FY | 35.7 Million USD | 4.08% |
| 1997 Q1 | 8.4 Million USD | -8.7% |
| 1996 FY | 34.3 Million USD | 23.38% |
| 1996 Q4 | 9.2 Million USD | 6.98% |
| 1996 Q3 | 8.6 Million USD | 2.38% |
| 1996 Q2 | 8.4 Million USD | 6.33% |
| 1996 Q1 | 7.9 Million USD | -1.25% |
| 1995 Q2 | 6.7 Million USD | 13.56% |
| 1995 FY | 27.8 Million USD | 23.01% |
| 1995 Q4 | 8 Million USD | 12.68% |
| 1995 Q3 | 7.1 Million USD | 5.97% |
| 1995 Q1 | 5.9 Million USD | -14.49% |
| 1994 FY | 22.6 Million USD | 32.94% |
| 1994 Q1 | 4.8 Million USD | -14.29% |
| 1994 Q2 | 5.4 Million USD | 12.5% |
| 1994 Q3 | 5.5 Million USD | 1.85% |
| 1994 Q4 | 6.9 Million USD | 25.45% |
| 1993 Q3 | 3.9 Million USD | -7.14% |
| 1993 Q4 | 5.6 Million USD | 43.59% |
| 1993 Q2 | 4.2 Million USD | -2.33% |
| 1993 Q1 | 4.3 Million USD | 22.86% |
| 1993 FY | 17 Million USD | 117.95% |
| 1992 Q1 | 2 Million USD | 11.11% |
| 1992 Q4 | 3.5 Million USD | 45.83% |
| 1992 FY | 7.8 Million USD | 239.13% |
| 1992 Q3 | 2.4 Million USD | 4.35% |
| 1992 Q2 | 2.3 Million USD | 15.0% |
| 1991 Q4 | 1.8 Million USD | 125.0% |
| 1991 Q1 | 400 Thousand USD | 104.21% |
| 1991 Q2 | 900 Thousand USD | 125.0% |
| 1991 FY | 2.3 Million USD | -8.0% |
| 1991 Q3 | 800 Thousand USD | -11.11% |
| 1990 FY | 2.5 Million USD | 192.59% |
| 1990 Q1 | 6.2 Million USD | 416.67% |
| 1990 Q2 | 6.3 Million USD | 1.61% |
| 1990 Q4 | -9.5 Million USD | -733.33% |
| 1990 Q3 | 1.5 Million USD | -76.19% |
| 1989 Q4 | 1.2 Million USD | 9.09% |
| 1989 Q1 | 1.1 Million USD | -35.29% |
| 1989 Q2 | 1.1 Million USD | 0.0% |
| 1989 Q3 | 1.1 Million USD | 0.0% |
| 1989 FY | -2.7 Million USD | -125.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -348.719% |
| AngioDynamics, Inc. | 154.69 Million USD | -63.319% |
| AtriCure, Inc. | 300.37 Million USD | 15.887% |
| Avinger, Inc. | 2 Million USD | -12513.63% |
| Azenta, Inc. | 263.14 Million USD | 3.986% |
| BioLife Solutions, Inc. | 46.75 Million USD | -440.407% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 89.285% |
| Daxor Corporation | 1.1 Million USD | -22796.669% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -2682.806% |
| Femasys Inc. | 691.9 Thousand USD | -36415.484% |
| GlucoTrack, Inc. | -13 Thousand USD | 1943569.231% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -315.094% |
| Hologic, Inc. | 2.22 Billion USD | 88.659% |
| ICU Medical, Inc. | 739.87 Million USD | 65.852% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 94.658% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -1412.13% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -98.861% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 211826.403% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 211826.403% |
| Masimo Corporation | 1 Billion USD | 74.823% |
| Microbot Medical Inc. | -106 Thousand USD | 238450.0% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -663.411% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 56.728% |
| Nephros, Inc. | 8.4 Million USD | -2905.961% |
| NovoCure Limited | 381.05 Million USD | 33.697% |
| NEXGEL, Inc. | 619 Thousand USD | -40715.994% |
| NEXGEL, Inc. | 619 Thousand USD | -40715.994% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 45377.957% |
| OraSure Technologies, Inc. | 179.42 Million USD | -40.815% |
| Pro-Dex, Inc. | 14.55 Million USD | -1636.314% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 21032.146% |
| Predictive Oncology Inc. | 1.14 Million USD | -21959.867% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -4257.722% |
| QuidelOrtho Corporation | 1.49 Billion USD | 83.093% |
| Repligen Corporation | 315.22 Million USD | 19.851% |
| Sanara MedTech Inc. | 57.13 Million USD | -342.183% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 28448.002% |
| Utah Medical Products, Inc. | 30.03 Million USD | -741.105% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 87.888% |
| Jin Medical International Ltd. | 6.78 Million USD | -3623.761% |